Clinical characteristics and outcomes of COVID-19 in children and adolescents with diabetes in Daegu, South Korea
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Children with comorbidities have a higher risk of severe, coronavirus disease 2019 (COVID-19). This study investigated the clinical features and outcomes of COVID-19 in children and adolescents with diabetes between January and March 2022.Methods: We retrospectively reviewed the medical records of 123 children and adolescents (73 with type 1 diabetes and 50 with type 2 diabetes, 59 males and 64 females) aged <18 years who had been diagnosed with diabetes. Data were collected from 7 academic medical centers in Daegu, South Korea.Results: Thirty-five children with diabetes were diagnosed with COVID-19 (18 with type 1 and 17 with type 2 diabetes). Eighteen of the 35 children with diabetes and COVID-19 and 50 of the 88 children with diabetes alone received a COVID-19 vaccination. No significant differences were observed between patients with diabetes and COVID-19 and patients with diabetes alone in the type of diabetes diagnosed, sex, age, body mass index, hemoglobin A1c, or vaccination status. All children with diabetes and COVID-19 had mild clinical features and were safely managed in their homes. Fourteen children had a fever of 38℃ or higher that lasted for more than 2 days, 11 of whom were not vaccinated (<i>p</i>=0.004). None experienced post-COVID-19 conditions.Conclusion: All children and adolescents with pre-existing diabetes had mild symptoms of COVID-19 due to low disease severity, high vaccination rates, uninterrupted access to medical care, and continuous glucose monitoring. Unvaccinated children with diabetes who experienced COVID-19 presented with higher and more frequent fevers compared to vaccinated children.
Abstract
Purpose: Children with comorbidities have a higher risk of severe, coronavirus disease 2019 (COVID-19). This study investigated the clinical features and outcomes of COVID-19 in children and adolescents with diabetes between January and March 2022.Methods: We retrospectively reviewed the medical records of 123 children and adolescents (73 with type 1 diabetes and 50 with type 2 diabetes, 59 males and 64 females) aged <18 years who had been diagnosed with diabetes. Data were collected from 7 academic medical centers in Daegu, South Korea.Results: Thirty-five children with diabetes were diagnosed with COVID-19 (18 with type 1 and 17 with type 2 diabetes). Eighteen of the 35 children with diabetes and COVID-19 and 50 of the 88 children with diabetes alone received a COVID-19 vaccination. No significant differences were observed between patients with diabetes and COVID-19 and patients with diabetes alone in the type of diabetes diagnosed, sex, age, body mass index, hemoglobin A1c, or vaccination status. All children with diabetes and COVID-19 had mild clinical features and were safely managed in their homes. Fourteen children had a fever of 38℃ or higher that lasted for more than 2 days, 11 of whom were not vaccinated (<i>p</i>=0.004). None experienced post-COVID-19 conditions.Conclusion: All children and adolescents with pre-existing diabetes had mild symptoms of COVID-19 due to low disease severity, high vaccination rates, uninterrupted access to medical care, and continuous glucose monitoring. Unvaccinated children with diabetes who experienced COVID-19 presented with higher and more frequent fevers compared to vaccinated children.
참고문헌 (32)
- Wang C, "A novel coronavirus outbreak of global health concern", Lancet, 395, pp.470~473 (2020)
- Lee H, "Analysis of critical COVID-19 cases among children in Korea", J Korean Med Sci, 37, pp.e13~ (2022)
- Choi YY, "SARS-CoV-2-Naïve Korean children and adolescents hospitalized with COVID-19 in 2021", J Korean Med Sci, 37, pp.e303~ (2022)
- Choi JH, "Risk factors for severe COVID-19 in children : a systematic review and metaanalysis", J Korean Med Sci, 37, pp.e35~ (2022)
- Shin E, "Pediatric deaths associated with coronavirus disease 2019(COVID-19)in Korea", J Korean Med Sci, 38, pp.e21~ (2023)
- Fadini GP, "Prevalence and impact of diabetes among people infected with SARSCoV-2", J Endocrinol Invest, 43, pp.867~869 (2020)
- Yang J, "Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2 : a systematic review and metaanalysis", Int J Infect Dis, 94, pp.91~95 (2020)
- Wu ZH, "Diabetes increases the mortality of patients with COVID-19 : a meta-analysis", Acta Diabetol, 58, pp.139~144 (2021)
- Scaramuzza AE, "Seasonal flu and COVID-19 recommendations for children, adolescents and young adults with diabetes", Diabet Med, 38, pp.e14427~ (2021)
- d'Annunzio G, "Caring for children and adolescents with type 1 diabetes mellitus : Italian Society for Pediatric Endocrinology and Diabetology(ISPED)statements during COVID-19 pandemia", Diabetes Res Clin Pract, 168, pp.108372~ (2020)
- Cardona-Hernandez R, "Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19", Pediatr Diabetes, 22, pp.202~206 (2021)
- Chiotos K, "Multicenter interim guidance on use of antivirals for children with coronavirus disease 2019", severe acute respiratory syndrome coronavirus 2, 2021, pp.10, 34~48
- Ryu BY, "Severity of COVID-19 associated with SARS-CoV-2variants circulating in the Republic of Korea", Public Health Weekly Report, 15, pp.2873~2895 (2022)
- American Diabetes Association, "2. Classification and diagnosis of diabetes : standards of medical care in diabetes-2019", Diabetes Care, 42(Suppl 1), pp.S13~S28 (2019)
- Kim JH, "The 2017 Korean National Growth Charts for children and adolescents : development, improvement, and prospects", Korean J Pediatr, 61, pp.135~149 (2018)
- "COVID-19vaccination. Revision of COVID-19 vaccination practice standards and related FAQ information"[URL]
- Butt AA, "Coronavirus disease 2019 disease severity in children infected with the omicron variant", Clin Infect Dis, 75, pp.e361~e367 (2022)
- Ahn SH, "Outbreak report of COVID-19 during designation of class 1 infectious disease in the Republic of Korea(January 20, 2020–April 24, 2022)", Public Health Wkly Rep, 15, pp.2126~2136 (2022)
- Al Agha AE, "Impact of COVID-19 lockdown on glycemic control in children and adolescents", Saudi Med J, 42, pp.44~48 (2021)
- Eberle C, "Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus : a systematic review", Review Diabetol Metab Syndr, 13, pp.95~ (2021)
- Cipolla C, "Eating habits and lifestyle in children with obesity during the COVID19 lockdown : a survey in an Italian center", Acta Biomed, 92, pp.e2021196~ (2021)
- Roh SM, "Does coronavirus disease 2019affect body mass index of children and adolescents who visited a growth clinic in South Korea? : a single-center study", Ann Pediatr Endocrinol Metab, 27, pp.52~59 (2022)
- Kang S, "Changes in lifestyle and obesity during the COVID-19 pandemic in Korean adolescents : based on the Korea Youth Risk Behavior Survey 2019 and 2020", Ann Pediatr Endocrinol Metab, 27, pp.281~288 (2022)
- Marks BE, "Increase in the diagnosis and severity of presentation of pediatric type 1 and type 2 diabetes during the COVID-19 pandemic", Horm Res Paediatr, 94, pp.275~284 (2021)
- Magge SN, "The coronavirus disease 2019 pandemic is associated with a substantial rise in frequency and severity of presentation of youth-onset type 2 diabetes", J Pediatr, 251, pp.51~59 (2022)
- Salmi H, "New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic", Arch Dis Child, 107, pp.180~185 (2022)
- Lee Y, "Comparison of initial presentation of pediatric diabetes before and during the coronavirus disease 2019 pandemic era", J Korean Med Sci, 37, pp.e176~ (2022)
- Chao LC, "Spike in diabetic ketoacidosis rates in pediatric type 2 diabetes during the COVID-19 pandemic", Diabetes Care, 44, pp.1451~1453 (2021)
- Chambers MA, "Increase in the number of pediatric new-onset diabetes and diabetic ketoacidosis cases during the COVID-19 pandemic", Endocr Pract, 28, pp.479~485 (2022)
- Barrett CE, "Risk for newly diagnosed diabetes >30days after SARS-CoV-2 infection among persons aged <18years-United States, March 1, 2020-June 28, 2021", Morb Mortal Wkly Rep, 71, pp.59~65 (2022)
- Kazakou P, "Diabetes and COVID-19; a bidirectional interplay", Front Endocrinol(Lausanne), 13, pp.780663~ (2022)
- Prosperi S, "COVID-19 and diabetes in children", Ann Pediatr Endocrinol Metab, 27, pp.157~168 (2022)